Autism spectrum disorder (ASD) is a complex neuro developmental condition characterized by significant genetic and phenotypic variability, making diagnosis and treatment challenging. The heterogeneity of ASD‐associated genetic variants and the absence of clear causal factors in many cases complicate personalized care. Traditional models, such as postmortem brain tissue and animal studies, have provided valuable insights but are limited in capturing the dynamic processes and human‐specific aspects of ASD pathology. Recent advances in human induced pluripotent stem cell (iPSC) technology have transformed ASD research by enabling the generation of patient‐derived neural cells in both two‐dimensional cultures and three‐dimensional brain organoid models. These models retain the donor's genetic background, allowing researchers to investigate disease‐specific cellular and molecular mechanisms while identifying potential therapeutic targets tailored to individual patients. This commentary highlights how stem cell‐based approaches are advancing our understanding of ASD and paving the way for more personalized diagnostic and therapeutic strategies.
Untangling the Molecular Mechanisms Contributing to Autism Spectrum Disorder Using Stem Cells
Published 2025 in Autism Research
ABSTRACT
PUBLICATION RECORD
- Publication year
2025
- Venue
Autism Research
- Publication date
2025-02-24
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
CITED BY
Showing 1-1 of 1 citing papers · Page 1 of 1